Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of the impact of pregnancy and malaria infection on the variation of neutrophil levels in women from San, Mali.
Djimde M, Arama C, Koné B, Diakité H, Keita M, Samaké MD, Tembely B, Bagayoko B, Traoré MB, Tshiongo JK, Mavoko HM, Dicko A, Vaillant M, Mens PF, Schallig HD, Kayentao K. Djimde M, et al. Among authors: diakite h. J Infect Dev Ctries. 2024 Apr 30;18(4):627-635. doi: 10.3855/jidc.18409. J Infect Dev Ctries. 2024. PMID: 38728650 Free article.
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol for a phase 3, non-inferiority, randomised open-label clinical trial.
Djimde M, Tshiongo JK, Muhindo HM, Tinto H, Sevene E, Traore M, Vala A, Macuacua S, Kabore B, Dabira ED, Erhart A, Diakite H, Keita M, Piqueras M, González R, Menendez C, Dorlo TP, Sagara I, Mens P, Schallig H, D'Alessandro U, Kayentao K. Djimde M, et al. Among authors: diakite h. BMJ Open. 2023 Oct 9;13(10):e065295. doi: 10.1136/bmjopen-2022-065295. BMJ Open. 2023. PMID: 37813539 Free PMC article.
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM). West African Network for Clinical Trials of Antimalarial Drugs (WANECAM). Lancet. 2018 Apr 7;391(10128):1378-1390. doi: 10.1016/S0140-6736(18)30291-5. Epub 2018 Mar 29. Lancet. 2018. PMID: 29606364 Free PMC article. Clinical Trial.
Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, Djimde M, Bationo R, Soulama A, Dabira E, Barry B, Niangaly M, Diakite H, Konate S, Keita M, Traore B, Meshnick SR, Magnussen P, Doumbo OK, ter Kuile FO. Coulibaly SO, et al. Among authors: diakite h. Malar J. 2014 Jan 31;13:41. doi: 10.1186/1475-2875-13-41. Malar J. 2014. PMID: 24484467 Free PMC article.